| |
|
|
Il Sung Pharm. (003120) |
|
|
STOCK |
|
|
|
  |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2004.12.31 | 2005.12.31 | 2006.12.31 | 2007.12.31 | 2008. 3.31 |
| Cash & Cash Equivalents | 18.1 | 72.4 | 208.4 | 56.0 | 16.0 |
| Short-term Financial Instruments | 5.0 | 9.0 | 110.1 | 0.0 | 196.9 |
| Marketable securities | 805.4 | 352.2 | 0.0 | 0.0 | 0.0 |
| Account receivables | 198.4 | 224.4 | 232.6 | 256.7 | 272.0 |
| TOTAL QUICK ASSETS | 1,030.2 | 662.4 | 563.7 | 320.4 | 524.9 |
| TOTAL INVENTORY | 127.1 | 125.6 | 145.1 | 158.4 | 153.5 |
| TOTAL CURRENT ASSETS | 1,157.4 | 788.1 | 708.9 | 478.8 | 678.5 |
| TOTAL INVESTMENTS ASSETS | 54.0 | 1,107.7 | 1,805.0 | 4,135.9 | 3,983.1 |
| TOTAL TANGIBLE ASSETS | 186.1 | 179.6 | 213.1 | 316.1 | 309.3 |
| TOTAL INTANGIBLE ASSETS | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 |
| TOTAL OTHER NON-CURRENT ASSETS | 7.5 | 6.0 | 6.8 | 9.5 | 8.6 |
| TOTAL NON-CURRENT ASSETS | 248.0 | 1,293.6 | 2,025.3 | 4,462.0 | 4,301.5 |
| TOTAL ASSETS | 1,405.4 | 2,081.7 | 2,734.2 | 4,940.8 | 4,980.1 |
| Trade account payable | 44.4 | 54.0 | 56.3 | 24.0 | 45.7 |
| Short-term borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 107.1 |
| Current portion of long-term liabilities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| TOTAL CURRENT LIABILITIES | 130.5 | 234.6 | 222.3 | 112.8 | 259.0 |
| Total bonds | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| TOTAL NON-CURRENT LIABILITIES | 8.2 | 90.8 | 209.0 | 827.7 | 788.0 |
| TOTAL LIABILITIES | 138.8 | 325.5 | 431.3 | 940.5 | 1,047.0 |
| Capital stocks | 133.0 | 133.0 | 133.0 | 133.0 | 133.0 |
| Capital surplus | 165.7 | 165.7 | 165.7 | 165.7 | 165.7 |
| Retained Earnings(Deficit) | 836.2 | 1,107.2 | 1,481.8 | 1,645.5 | 1,697.4 |
| TOTAL STOCKHOLDERS EQUITY | 1,266.5 | 1,756.2 | 2,302.9 | 4,000.3 | 3,933.0 |
|
 |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2004.12.31 | 2005.12.31 | 2006.12.31 | 2007.12.31 | 2008. 3.31 |
| SALES(NET) | 714.8 | 771.7 | 785.8 | 788.3 | 210.6 |
| Cost of Sales | 388.8 | 390.1 | 372.0 | 370.2 | 108.0 |
| GROSS PROFIT | 326.0 | 381.6 | 413.8 | 418.0 | 102.5 |
| Seling & General Admin. Expenses | 162.5 | 182.2 | 202.7 | 213.5 | 47.2 |
| OPERATING INCOME | 163.4 | 199.3 | 211.1 | 204.5 | 55.3 |
| NON-OPERATING INCOME | 62.3 | 213.2 | 337.8 | 75.3 | 37.3 |
| Gain on valuation using equity method of accounting | - | - | - | - | - |
| NON-OPERATING EXPENSES | 11.8 | 16.1 | 6.1 | 18.6 | 3.6 |
| Loss on valuation using equity method of accounting | - | - | - | - | - |
| Ongoing Business Income(Loss) Before Income Taxes Expenses | 213.8 | 396.4 | 542.8 | 261.1 | 89.0 |
| Income Taxes Expenses for Ongoing Business Income or Loss | 70.6 | 114.8 | 157.5 | 84.1 | 24.1 |
| ONGOING BUSINESS INCOME(LOSS) | 143.2 | 281.6 | 385.2 | 177.0 | 64.9 |
| DISCONTINUED OPERATION INCOME(LOSS) | - | - | - | - | - |
| NET INCOME | 143.2 | 281.6 | 385.2 | 177.0 | 64.9 |
|
 |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2003.12.31 | 2004.12.31 | 2005.12.31 | 2006.12.31 | 2007.12.31 |
| Cash flows from operating activities |
139.2 | 199.6 | 177.8 | 118.9 | 41.7 |
| Add.of Cost without outflow of Cash |
30.1 | 30.1 | 44.7 | 30.0 | 24.9 |
| Depreciation |
16.2 | 19.7 | 18.5 | 17.3 | 17.3 |
| Deduc.of Rev.without inflow of Cash |
0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Loss on Disposition of Invest.Assets |
1.1 | 0.2 | 166.9 | 288.6 | 36.5 |
| Changes in Ass. & Liab. resulting from operating Activities |
- 3.9 | 26.4 | 18.4 | - 7.7 | - 123.6 |
| Cash flows from investing activities |
- 118.1 | - 350.6 | - 112.9 | 27.9 | - 136.6 |
| Inflow of cash |
95.4 | 64.9 | 601.7 | 387.0 | 764.2 |
| Outflow of cash |
213.6 | 415.5 | 714.6 | 359.0 | 900.8 |
| Cash flows from financing activities |
- 13.3 | - 7.9 | - 10.6 | - 10.8 | - 57.4 |
| Inflow of cash |
- | - | - | - | - |
| Outflow of cash |
13.3 | 7.9 | 10.6 | 10.8 | 57.4 |
| Increase in Cash |
7.8 | - 159.0 | 54.2 | 136.0 | - 152.3 |
|
|
|
|
